2020
DOI: 10.31557/apjcp.2020.21.9.2771
|View full text |Cite
|
Sign up to set email alerts
|

Network-Based Analysis Reveals Association of FOXE1 Gene Polymorphisms in Thyroid Cancer Patients; A Case-Control Study in Southeast of Iran

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
3
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(5 citation statements)
references
References 32 publications
1
3
0
Order By: Relevance
“…This study also shows that lymphomas and tumors of the cranial nerves including schwannoma are uncommon in our environment unlike other parts of the world. 8 , 9 , 12 , 13 , 15 Similar observation was made by Ndubuisi et al 21 …”
Section: Discussionsupporting
confidence: 80%
See 3 more Smart Citations
“…This study also shows that lymphomas and tumors of the cranial nerves including schwannoma are uncommon in our environment unlike other parts of the world. 8 , 9 , 12 , 13 , 15 Similar observation was made by Ndubuisi et al 21 …”
Section: Discussionsupporting
confidence: 80%
“…These findings are similar to that of Malami 23 This study also shows that lymphomas and tumors of the cranial nerves including schwannoma are uncommon in our environment unlike other parts of the world. 8,9,12,13,15 Similar observation was made by Ndubuisi et al 21 Result of most studies, including those done in Nigeria and globally, showed equal rate of occurrence of intracranial tumors in both genders or a slight male preponderance; many reported a male to female ratio of 1:1. 6,7,14,18,19,20,21,22 However, our study showed a slight female preponderance in the rate of occurrence of intracranial tumors with male to female ratio of 1:1.3.…”
Section: Discussionsupporting
confidence: 72%
See 2 more Smart Citations
“…However, the previously mentioned study was conducted mainly on Caucasians, with a small sample of Asian studies. Recently, a case-control study conducted in Iran on 81 patients with thyroid cancer and 165 controls found that FOXE1 polymorphism (rs1867277) could be used as a biomarker for thyroid cancer diagnosis, being found in 32.1% (homozygous GG) and 18.5% (homozygous AA) of thyroid cancer patients [ 69 ].…”
Section: Single Nucleotide Polymorphism and Thyroid Cancermentioning
confidence: 99%